Here are seven gastroenterology drugs and technologies that have been approved or cleared by the FDA in the past five months: 1. Voquezna Triple Pak and Voquezna Dual Pak, which both treat ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

A rise in popularity in glucagon-like peptide 1 receptor agonists such as Ozempic and Wegovy is causing concern in the medical community over potential side effects for various physician specialties, ...

Ionis Pharmaceuticals has signed the rights to another antisense drug over to Janssen for a fee of $5 million. The candidate, IONIS-JBI2-2.5Rx, is orally delivered and acts on an undisclosed target to ...

Ironwood Pharmaceuticals, a company whose drug research yielded a blockbuster gastrointestinal disorder drug, has struck a $1 billion deal to acquire VectivBio, a biotech whose lead program brings ...

In the general patient population, low-dose aspirin almost doubles the likelihood of upper gastrointestinal (GI) bleeding, and adding drugs such as clopidogrel or high-dose corticosteroids raises the ...

Identify and compare mechanisms of action, safety, tolerability, and efficacy profiles of emerging therapies for common gastrointestinal (GI) disorders Recognize the roles of emerging therapies for ...

FORT LAUDERDALE, FL / ACCESS Newswire / March 10, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic ...

Inspired by kirigami, the Japanese art of folding and cutting paper, engineers have designed a new type of stent that could be used to deliver drugs to the gastrointestinal tract, respiratory tract, ...